Chronic obstructive pulmonary disease
Conditions
Interventions
Intervention group:Patients were closely followed up using the informatized SOP management system.
Control group:Usual Care
Sponsors
The First Affiliated Hospital of Kunming Medical University
Eligibility
Sex/Gender
All
Age
40 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Diagnosed with COPD; (2) Hospitalized for acute exacerbation of COPD and meeting discharge criteria (the patient is deemed by the clinician to be suitable for home healthcare; the patient can use long-acting bronchodilators, ß2-agonists and/or anticholinergics, with or without inhaled corticosteroids for stable-phase inhalation therapy, with short-acting ß2-agonists used less than every 4 hours; if the patient was not previously bedridden, they must be able to walk indoors; the patient can eat, and sleep is unaffected by dyspnea; clinically stable for 12–24 hours; arterial blood gas analysis stable for 12–24 hours; the patient (or family) fully understands the correct use of stable-phase medications; follow-up and home care plans are properly arranged); (3) Age >=40 years; (4) Clinically assessed post-discharge for treatment with Budesonide/Glycopyrronium/Formoterol Inhalation Aerosol; (5) Signed informed consent; (6) Able to independently or with assistance use a smartphone for information reporting.
Exclusion criteria
Exclusion criteria: (1) Severe life-threatening comorbidities with an expected survival <=1 year: severe heart disease, severe chronic liver/kidney disease, bedridden cerebrovascular disease, malignancies, etc.; (2) Long-term corticosteroid use for pre-existing conditions (e.g., asthma, interstitial lung disease, sarcoidosis, cystic fibrosis) or conditions precluding future inhaled steroid use (e.g., active tuberculosis, uncontrolled infections); (3) Residence outside the service area of participating hospitals; (4) Participation in any other interventional study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Moderate/severe acute exacerbation rate;All-cause readmission rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of patient compliance of inhalation therapy;Correct usage rate and improvement rate of inhalation devices;COPD Assessment Test;Modified British medical research council;St George's Respiratory Questionnaire;Self-Rating Anxiety Scale;Self-Rating Depression Scale;Borg Dyspnoea Scale;Fagerstrom Test for Nicotine Dependence;Pittsburgh sleep quality index;Complete Blood Count;Arterial blood gas analysis;Pulmonary Function;Saturation of Peripheral Oxygen;Blood pressure;Heart rate;Major Adverse Cardiovascular Events;All-cause mortality;Cost of treatment; | — |
Countries
China
Contacts
Public ContactLuo Zhuang
The First Affiliated Hospital of Kunming Medical University
Outcome results
None listed